Inventor · disambiguated record
Maria Pilar Pizcueta Lalanza
Also filed as: PIZCUETA LALANZA MARIA PILAR
5 granted patents·7 pending applications·17 citations·filing 2009–2024
73Inventor score
Top patents by PatentIndex Score
12 records- 0189US9782395B22,4-thiazolidinedione derivatives in the treatment of central nervous system disordersMINORYX THERAPEUTICS S L·Filed 2016·Granted Oct 10, 2017·13 cites·22 claims
- 0277US10179126B22,4-thiazolidinedione derivatives in the treatment of central nervous system disordersMINORYX THERAPEUTICS S L·Filed 2017·Granted Jan 15, 2019·2 cites·26 claims
- 0369US2025064791A15-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseasesMINORYX THERAPEUTICS S L·Filed 2024·Application pending·0 cites
- 0468US2024091210A1Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its saltsMINORYX THERAPEUTICS S L·Filed 2023·Application pending·0 cites
- 0559US8865728B2Combinations comprising methotrexate and DHODH inhibitorsGODESSART MARINA NURIA·Filed 2009·Granted Oct 21, 2014·2 cites·17 claims
- 0655US11938122B25-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione for treating nonalcoholic fatty liver diseaseMINORYX THERAPEUTICS S L·Filed 2017·Granted Mar 26, 2024·0 cites·13 claims
- 0753US2019255032A12,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System DisordersMINORYX THERAPEUTICS S L·Filed 2018·Application pending·0 cites
- 0852US11957670B25-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseasesMINORYX THERAPEUTICS S L·Filed 2019·Granted Apr 16, 2024·0 cites·18 claims
- 0950US2021228558A1Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its saltsMINORYX THERAPEUTICS S L·Filed 2019·Application pending·0 cites
- 1048US2021308113A1Method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dioneMINORYX THERAPEUTICS S L·Filed 2019·Application pending·0 cites
- 1148US2023172921A1Leriglitazone for treating lung inflammation and interstitial lung diseaseMINORYX THERAPEUTICS S L·Filed 2021·Application pending·0 cites
- 1218US2011280831A1Combinations comprising methotrexate and dhodh inhibitorsGODESSART MARINA NURIA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maria Pilar Pizcueta Lalanza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →